We are live on
!
Find out more
GP
GLG Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
21.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
(+13%)
Cap. Flow
-$237M
Cap. Flow
% of AUM
-11.11%
Top 10 Holdings %
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Top Buys
| 1 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$46.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$35M |
| 3 |
MON
Monsanto Co
MON
|
+$29.2M |
| 4 |
CYOU
Changyou.com Limited American Depositary Share
CYOU
|
+$22.9M |
| 5 |
Dell
DELL
|
+$22.8M |
Top Sells
| 1 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
+$29M |
| 2 |
RICE
Rice Energy Inc.
RICE
|
+$23M |
| 3 |
Criteo
CRTO
|
+$22.5M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$18M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$15.8M |
Sector Composition
| 1 | Consumer Discretionary | 13.24% |
| 2 | Technology | 9.69% |
| 3 | Financials | 9.4% |
| 4 | Industrials | 8.58% |
| 5 | Materials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Quest Diagnostics
DGX
$23.2B
| $162K | 0.01% |
+1,645
| New | +$156K |
|
327
Danaher
DHR
$145B
| $159K | 0.01% |
+1,933
| New | +$157K |
|
328
Cytosorbents Corp
CTSO
$23.2M
| $156K | 0.01% |
+24,047
| New | +$153K |
|
|
CSRA
329
DELISTED
CSRA Inc.
CSRA
| $154K | 0.01% |
5,160
| – | – |
|
330
Helmerich & Payne
HP
$3.34B
| $153K | 0.01% |
+2,360
| New | +$132K |
|
331
Alnylam Pharmaceuticals
ALNY
$37.8B
| $152K | 0.01% |
+1,200
| New | +$151K |
|
332
Prospect Capital
PSEC
$1.17B
| $152K | 0.01% |
+22,600
| New | +$147K |
|
|
TYME
333
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $152K | 0.01% |
+23,820
| New | +$106K |
|
334
Archer Daniels Midland
ADM
$40B
| $151K | 0.01% |
+3,775
| New | +$155K |
|
335
American International
AIG
$41.4B
| $150K | 0.01% |
+2,524
| New | +$155K |
|
336
Realty Income
O
$61.3B
| $150K | 0.01% |
+2,713
| New | +$147K |
|
337
Huntington Ingalls Industries
HII
$10.7B
| $141K | 0.01% |
600
-900
| -60% | -$212K |
|
338
Costco
COST
$419B
| $140K | 0.01% |
+752
| New | +$130K |
|
339
Fortinet
FTNT
$118B
| $131K | 0.01% |
15,000
-4,430
| -23% | -$36.1K |
|
340
Saic
SAIC
$4.86B
| $130K | 0.01% |
1,700
-366
| -18% | -$26.5K |
|
|
CLVS
341
DELISTED
Clovis Oncology, Inc.
CLVS
| $128K | 0.01% |
1,886
-347
| -16% | -$24.3K |
|
342
Arrowhead Research
ARWR
$10.1B
| $118K | 0.01% |
+31,974
| New | +$119K |
|
343
Acadia Pharmaceuticals
ACAD
$4.39B
| $114K | 0.01% |
+3,794
| New | +$121K |
|
344
Booz Allen Hamilton
BAH
$7.83B
| $114K | 0.01% |
3,000
-3,000
| -50% | -$113K |
|
345
Dentsply Sirona
XRAY
$2.77B
| $114K | 0.01% |
+1,737
| New | +$110K |
|
346
Truist Financial
TFC
$66.3B
| $113K | 0.01% |
+2,269
| New | +$110K |
|
347
Corning
GLW
$136B
| $109K | 0.01% |
3,400
+347
| +11% | +$10.9K |
|
348
US Bancorp
USB
$99.7B
| $107K | 0.01% |
+2,004
| New | +$108K |
|
349
Exelon
EXC
$47.9B
| $106K | 0.01% |
+3,767
| New | +$108K |
|
350
Merck
MRK
$315B
| $105K | ﹤0.01% |
+1,952
| New | +$108K |
|
Similar funds
IH
GL
TAM
SI
GES
AS
QAM
BTIS